Form 8-K
8-K — Acadia Healthcare Company, Inc.
Accession: 0001193125-26-173769
Filed: 2026-04-23
Period: 2026-04-22
CIK: 0001520697
SIC: 8093 (SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC)
Item: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item: Regulation FD Disclosure
Item: Financial Statements and Exhibits
Documents
8-K — d116826d8k.htm (Primary)
EX-10.1 (d116826dex101.htm)
EX-99.1 (d116826dex991.htm)
GRAPHIC (g116826g0423113206080.jpg)
XML — IDEA: XBRL DOCUMENT (R1.htm)
8-K
8-K (Primary)
Filename: d116826d8k.htm · Sequence: 1
8-K
false 0001520697 0001520697 2026-04-22 2026-04-22
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): April 22, 2026
Acadia Healthcare Company, Inc.
(Exact Name of Registrant as Specified in Its Charter)
Delaware
001-35331
45-2492228
(State or Other Jurisdiction
of Incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)
4020 Aspen Grove Drive, Suite 900
Franklin, Tennessee
37067
(Address of Principal Executive Offices)
(Zip Code)
(615) 861-6000
(Registrant’s Telephone Number, including Area Code)
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (See General Instruction A.2. below):
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading
Symbol
Name of each exchange
on which registered
Common Stock, $0.01 par value
ACHC
NASDAQ Global Select Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
Chief Financial Officer Departure
On April 23, 2026, Acadia Healthcare Company, Inc. (“Acadia” or the “Company”) announced that Todd Young will resign as Chief Financial Officer of Acadia, effective as of April 30, 2026.
Interim Chief Financial Officer Appointment
Also on April 23, 2026, Acadia announced that Acadia’s Board of Directors (the “Board”) has appointed David M. Duckworth as the Interim Chief Financial Officer of Acadia, effective as of the May 1, 2026. Mr. Duckworth has also been designated as the Company’s principal financial officer.
Mr. Duckworth, age 46, previously served as Chief Financial Officer of Acadia from July 2012 to July 2023, having joined Acadia as Controller in April 2011 and becoming Chief Accounting Officer in January 2012 and Chief Financial Officer in July 2012. From May 2010 to April 2011, Mr. Duckworth served as Director of Finance at Emdeon Inc., a leading provider of revenue and payment cycle management and clinical information exchange solutions. Prior to joining Emdeon, Mr. Duckworth was a Manager with Ernst & Young LLP, which he joined in 2002.
There are no arrangements or understandings between Mr. Duckworth and any other person pursuant to which Mr. Duckworth was appointed as Interim Chief Financial Officer of Acadia, and there are no family relationships among any of the Company’s directors or executive officers and Mr. Duckworth. Mr. Duckworth does not have any direct or indirect material interest in any transaction or proposed transaction required to be reported under Item 404(a) of Regulation S-K.
In connection with the appointment of Mr. Duckworth as Interim Chief Financial Officer of Acadia, Mr. Duckworth and Acadia Management Company, LLC, a Delaware limited liability company, entered into an employment agreement, effective as of April 27, 2026 (the “Start Date”) (the “Duckworth Employment Agreement”).
The Duckworth Employment Agreement provides for an initial fixed term of employment commencing as of the Start Date and ending on May 1, 2027. Following such period, the term of Mr. Duckworth’s employment with the Company pursuant to the Duckworth Employment Agreement will be automatically renewed for consecutive one-year periods, unless either party provides 90 days’ prior written notice of non-renewal.
Pursuant to the Duckworth Employment Agreement, Mr. Duckworth (a) will receive a base salary at a monthly rate of $100,000 and (b) will be eligible to receive a quarterly cash bonus equal to $125,000 per quarter. Further, in the event that Mr. Duckworth’s employment is terminated without “cause” (which for the avoidance of doubt does not include a non-renewal of the employment term by the Company) or if Mr. Duckworth resigns his employment for “good reason” (each as defined in the Duckworth Employment Agreement), Mr. Duckworth will receive the following severance benefits, subject to Mr. Duckworth’s timely execution and non-revocation of a general release of claims in favor of Acadia (and certain of its affiliates and related parties, including, without limitation, Acadia Management Company, LLC) and compliance with restrictive covenants (as further described below): (i) solely to the extent that such termination occurs during the first six months of the initial term of Mr. Duckworth’s employment, an amount equal to the base salary Mr. Duckworth would have received during the remainder of such six-month period absent his termination of employment, payable in a lump sum within sixty days following the termination date; and (ii) solely to the extent that such termination occurs in connection with the hiring of a permanent Chief Financial Officer of Acadia, a cash payment equal to $350,000, payable in a lump sum within sixty days following the termination date (and subject to Mr. Duckworth’s provision of reasonable transition services).
Pursuant to the Duckworth Employment Agreement, Mr. Duckworth will be subject to customary confidentiality and intellectual property assignment covenants, as well as non-competition, non-solicitation and non-disparagement covenants during the term of his employment and for specified periods thereafter.
The foregoing description of the Duckworth Employment Agreement is qualified in its entirety by the full text thereof, a copy of which is attached as Exhibit 10.1 and incorporated by reference herein.
In connection with his appointment as Interim Chief Financial Officer, the Company has also entered into its standard form of indemnity agreement, a copy of which is attached as Exhibit 10.2 and incorporated by reference herein, with Mr. Duckworth.
Item 7.01
Regulation FD Disclosure.
On April 23, 2026, Acadia issued a press release in connection with the foregoing Chief Financial Officer transition. The press release is furnished herewith as Exhibit 99.1 hereto and is incorporated herein by reference.
The information furnished pursuant to Item 7.01 in this Current Report on Form 8-K, including Exhibit 99.1, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.
Item 9.01
Financial Statements and Exhibits.
(d)
Exhibits
10.1
Employment Agreement, effective as of April 27, 2026, by and between Acadia Management Company, LLC and David M. Duckworth
10.2
Form of Indemnification Agreement (for directors and officers not affiliated with Waud Capital Partners) (Incorporated by reference to Exhibit 10.3 to the Company’s Current Report on Form 8-K filed November 1, 2011 (File No. 001-35331))
99.1
Press Release, dated April 23, 2026
104
Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: April 23, 2026
ACADIA HEALTHCARE COMPANY, INC.
By:
/s/ Brian P. Farley
Brian P. Farley
Executive Vice President, Secretary
and General Counsel
EX-10.1
EX-10.1
Filename: d116826dex101.htm · Sequence: 2
EX-10.1
Exhibit 10.1
EXECUTION VERSION
EMPLOYMENT AGREEMENT
THIS EMPLOYMENT AGREEMENT (this “Agreement”) is entered into as of April 22, 2026 (the “Signing
Date”) and effective as of the Start Date (as defined below), by and between Acadia Management Company, LLC, a Delaware limited liability company (the “Company”), and David M. Duckworth (“Executive”).
WHEREAS, the Company desires to employ Executive, and Executive desires to be employed by and render services to the Company and its
respective affiliates, on the terms and conditions set forth in this Agreement.
NOW, THEREFORE, in consideration of the mutual covenants
contained herein and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows:
1. Employment; Employment Period. The Company shall employ Executive, and Executive hereby accepts such employment with the Company,
upon the terms and conditions set forth in this Agreement for the period beginning April 27, 2026 (the “Start Date”) and ending May 1, 2027 (such period, the “Initial Term”). Thereafter, the term of
Executive’s employment with the Company under this Agreement shall extend automatically for consecutive periods of one (1) year (each, a “Renewal Term”), unless either party provides written notice of non-renewal to the other party no less than ninety (90) days prior to the end of the employment term as then in effect, or unless Executive’s employment with the Company hereunder is terminated
pursuant to Section 4 hereof. The Initial Term together with any Renewal Term shall collectively be referred to herein as the “Employment Period.” During the Employment Period, Executive’s
principal place of employment will be in Franklin, Tennessee; provided, that Executive will be required to travel from time to time on Company business during the Employment Period.
2. Position and Duties.
(a) Position; Responsibilities. During the (i) portion of the Employment Period commencing on the Start Date and ending
April 30, 2026 (the “Transition Date”), Executive shall serve as the Executive Advisor to the CEO of the Company and Acadia Healthcare Company, Inc., a Delaware corporation (“Acadia”); and (ii) as of
May 1, 2026 and for the remainder of the Employment Period, Executive shall serve as the Interim Chief Financial Officer of the Company and Acadia and, in each case, shall have the normal duties, responsibilities, functions and authority
consistent with such position (as applicable), subject to the power and authority of the board of directors of Acadia (the “Board”).
(b) Reporting; Performance of Duties. During the Employment Period, Executive shall report to the Chief Executive Officer of Acadia
and shall devote substantially all of Executive’s business time and attention (except for permitted vacation periods and reasonable periods of illness or other incapacity, in each case, taken in accordance with the terms of applicable policies
and benefit plans of the Company) to the business and affairs of Acadia and the Subsidiaries. So long as Executive is employed by the Company, Executive shall not, without the prior written consent or approval of the Board, perform other services
for compensation. Notwithstanding the foregoing, nothing herein shall preclude Executive from, during the
Employment Period, (i) serving, with the prior written consent of the Board (not to be unreasonably withheld), as a member of the boards of directors or advisory boards (or their equivalents
in the case of a non-corporate entity) of for-profit companies or businesses which are not directly competitive with the Company or any Subsidiary (provided that the
prior written consent of the Board shall not be required for Executive to serve as a member of the boards of directors or advisory boards (or their equivalents) of the companies listed on Exhibit A attached hereto), (ii) engaging in
charitable activities and community affairs (including serving as a member of the boards of directors or advisory boards (or their equivalents in the case of a non-corporate entity) of not-for-profit, charitable or community organizations which are not directly competitive with the Company or any Subsidiary), and (iii) managing Executive’s
personal and legal affairs and passive personal investments; provided, however, the activities set out in clauses (i) and (ii) above shall be limited by Executive so as not to materially interfere, individually or in the aggregate, with the
performance of Executive’s duties and responsibilities hereunder. For the avoidance of doubt, so long as Executive is employed by the Company, Executive shall not provide any services to any company or business that is directly competitive
with Acadia or the Subsidiaries (whether for-profit or not-for-profit) without the prior written consent of the Board.
3. Compensation and Benefits.
(a) Base Salary. During the Employment Period, Executive’s base salary shall be $100,000 per month, subject to adjustment by the
Board or Acadia’s Compensation Committee (the “Compensation Committee”) in its sole discretion (as adjusted from time to time, the “Base Salary”), which salary shall be payable by the Company in regular
installments in accordance with the Company’s general payroll practices (as in effect from time to time). The Base Salary for any partial year during the Employment Period will be based upon the actual number of days elapsed in such year.
(b) Bonus. Commencing with the Company’s fiscal quarter ending June 30, 2026 and for each complete fiscal quarter
thereafter during the Employment Period, Executive will be eligible to receive a quarterly cash bonus equal to $125,000. Unless otherwise agreed to by Executive, any such bonus amount for any quarter shall be earned forty-five (45) days
following the last day of such quarter and paid in the first normal payroll period after such date, subject to Executive’s continued employment pursuant to this Agreement through the applicable payment date.
(c) Business Expenses. During the Employment Period, the Company shall reimburse Executive
bi-weekly in accordance with the Company’s customary payroll practices for all reasonable out-of-pocket business expenses
incurred by Executive in the course of performing Executive’s duties and responsibilities under this Agreement that are consistent with the Company’s policies in effect from time to time with respect to travel, lodging, meals,
entertainment and other business expenses, subject to the Company’s requirements with respect to reporting and documentation of such expenses.
(d) Benefits. In addition to (but without duplication of) the Base Salary and any bonuses payable to Executive pursuant to this
Section 3, Executive shall be entitled to participate at Executive’s sole discretion in all of the Company’s employee benefit programs for which senior executive employees of the Company are generally eligible.
2
4. Termination.
(a) Termination. The Employment Period shall terminate automatically and immediately upon Executive’s resignation for any reason
(whether with Good Reason or without Good Reason), Executive’s death or becoming Disabled, or upon the termination of Executive’s employment by the Company (through action by the Board) for any reason (whether for Cause or without
Cause). The date on which Executive ceases to be employed by the Company is referred to herein as the “Termination Date.” Upon termination of the Employment Period for any reason or no reason, Executive will be deemed to have
automatically resigned from all positions that Executive holds with the Company, Acadia or any of the Subsidiaries, including, without limitation, as a member of the Board or as an officer, director or fiduciary of the Company, Acadia or any of the
Subsidiaries, and Executive hereby agrees that Executive shall take all actions reasonably requested by Acadia to give effect to the foregoing.
(b) Termination without Cause or with Good Reason. If the Employment Period is terminated by the Company without Cause (which, for the
avoidance of doubt, shall not include a non-renewal of the Employment Period by the Company pursuant to Section 1 hereof) or by Executive with Good Reason (each, a
“Qualifying Termination”), then Executive shall be entitled to receive:
(i) Executive’s unpaid Base Salary
through the Termination Date (payable in accordance with Section 3(a), or such earlier date required by law), any earned but unpaid cash bonus with respect to a completed performance period (payable at the same time that
such bonuses are generally paid to other senior executive employees of the Company), payment in respect of any unused paid time off and sick pay of Executive in such amounts as have accrued as of the Termination Date in accordance with the
Company’s policies with respect thereto as in effect during the Employment Period, reimbursement of any business expenses incurred by Executive but not reimbursed prior to the Termination Date in accordance with and reimbursable under the
terms of the Company’s policies with respect thereto as in effect on the Termination Date (in each case, payable in a lump sum within ten (10) business days after the Termination Date), and all other payments, benefits or fringe benefits
to which Executive shall be entitled under the terms of any applicable compensation arrangement or benefit plan or program of the Company (the payments under this Section 4(b)(i), collectively, the “Accrued Benefits”);
(ii) Solely to the extent that the Qualifying Termination occurs during the first six-(6) months of
the Initial Term of the Employment Period (such six-(6) month period, the “Severance Period”), an amount equal to the Base Salary Executive would have received during the remainder of the
Severance Period absent Executive’s termination of employment, payable in a lump sum within sixty (60) days following the Termination Date; and
(iii) Solely to the extent that the Qualifying Termination occurs in connection with the hiring of a permanent Chief Financial Officer of the
Company and Acadia, a cash payment equal to $350,000, payable in a lump sum within sixty (60) days following the Termination Date (subject to Executive’s provision of reasonable transition services as reasonably requested by the Company
and Acadia following the hiring of such permanent Chief Financial Officer).
3
Notwithstanding the foregoing, Executive shall not be entitled to receive the benefits provided for in
Sections 4(b)(ii) and 4(b)(iii) above unless and until Executive signs and delivers and does not revoke the General Release substantially in the form attached hereto as Exhibit B; and provided further that Executive has
not breached any of the provisions of Sections 5, 6 and 7 hereof.
(c) Other Termination. If the Employment
Period is terminated other than by the Company without Cause or by Executive with Good Reason, Executive shall be entitled to receive only the Accrued Benefits.
(d) Long-Term Incentive Compensation. Upon any termination of employment, the terms of the applicable award agreement shall govern the
treatment of Executive’s outstanding equity awards.
(e) No Mitigation. Executive is under no obligation to mitigate damages
or the amount of any payment provided for under this Section 4 by seeking other employment or otherwise.
(f)
Right of Offset. The Company may offset any bona fide obligations that Executive owes Acadia or any of the Subsidiaries (which for the avoidance of doubt shall not include any unliquidated obligations or obligations to the extent Executive
disputes in good faith the nature or amount thereof) against any amounts the Company or any of the Subsidiaries owes Executive hereunder; provided that, notwithstanding the foregoing or any other provision of this Agreement to the contrary,
in no event shall any payment under this Agreement that constitutes “deferred compensation” for purposes of Code Section 409A be subject to offset, counterclaim or recoupment by any other amount unless otherwise permitted by Code
Section 409A.
(g) Section 409A Compliance.
(i) The intent of the parties is that payments and benefits under this Agreement be exempt from or comply with Section 409A of the
Internal Revenue Code of 1986, as amended (the “Code”) and the regulations and guidance promulgated thereunder (collectively “Code Section 409A”) and, accordingly, to the maximum extent
permitted, this Agreement shall be interpreted and administered to be exempt from or in compliance therewith. In no event whatsoever shall Acadia or any of the Subsidiaries be liable for any additional tax, interest or penalty that may be imposed on
Executive by Code Section 409A or damages for failing to comply with Code Section 409A.
(ii) A termination of employment shall
not be deemed to have occurred for purposes of any provision of this Agreement providing for the payment of any amounts or benefits upon or following a termination of employment unless such termination is also a “separation from service”
within the meaning of Code Section 409A and, for purposes of any such provision of this Agreement, references to a “termination,” “termination of employment,” “termination of the Employment Period” or like
terms shall mean “separation from service.”
(iii) All expenses or other reimbursements under this Agreement shall be made on
or prior to the last day of the taxable year following the taxable year in which such expenses were incurred by Executive (provided that if any such reimbursements constitute taxable income to Executive, such reimbursements shall be paid no later
than March 15th of the calendar year following the calendar year in which the expenses to be reimbursed were incurred), and no such reimbursement or expenses eligible for reimbursement in any taxable year shall in any way affect the expenses
eligible for reimbursement in any other taxable year.
4
(iv) Whenever a payment under this Agreement specifies a payment period with reference to a
number of days (e.g., “payment shall be made within fifteen (15) days following the Termination Date”), the actual date of payment within the specified period shall be within the sole discretion of the Company.
(v) Notwithstanding any other payment schedule provided herein to the contrary, if Executive is deemed on the Termination Date to be a
“specified employee” within the meaning of that term under Code Section 409A(a)(2)(B), then any payment that is considered deferred compensation under Code Section 409A payable on account of a “separation from
service” shall be made on the date which is the earlier of (a) the expiration of the six (6)-month period measured from the date of such “separation from service” of Executive and (b) the date of Executive’s death
(the “Delay Period”) to the extent required under Code Section 409A. Upon the expiration of the Delay Period, all payments delayed pursuant to the immediately preceding sentence (whether they otherwise would have been payable
in a single sum or in installments in the absence of such delay) shall be paid to Executive in a lump sum, and all remaining payments due under this Agreement shall be paid or provided in accordance with the normal payment dates specified for them
herein. In addition, if Executive is a “specified employee,” to the extent that welfare benefits to be provided to Executive pursuant to this Agreement are not “disability pay,” “death benefit” plans or non-taxable medical benefits within the meaning of Treasury Regulation Section 1.409A-1(a)(5) or other benefits not considered nonqualified deferred compensation within
the meaning of that regulation, such provision of benefits shall be delayed until the end of the Delay Period. Notwithstanding the foregoing, to the extent that the previous sentence applies to the provision of any ongoing health or welfare benefits
that would not be required to be delayed if the premiums were paid by Executive, Executive shall pay the full cost of the premiums for such benefits during the Delay Period and the Company shall pay Executive an amount equal to the amount of such
premiums paid by Executive during the Delay Period within ten (10) days after the end of the Delay Period.
5. Confidential
Information.
(a) Protection of Confidential Information. Executive acknowledges that the continued success of Acadia depends
upon the use and protection of a large body of confidential and proprietary information. All of such confidential and proprietary information now existing or to be developed in the future will be referred to in this Agreement as
“Confidential Information.” Confidential Information will be interpreted broadly to include, without limitation, all information that is (i) related to Acadia’s (including any of its predecessors’ prior to being
acquired by Acadia) current or potential business and (ii) is not generally or publicly known (including, without specific limitation, the information, observations and data concerning (A) acquisition opportunities in or reasonably related
to Acadia’s business or industry, (B) identities and requirements of, contractual arrangements with and other information regarding Acadia’s employees (including personnel files and other information), suppliers, distributors,
customers, independent contractors, third-party payors, providers or other business relations and their confidential information, including, without limitation, patient records, medical histories and other information concerning patients (including,
5
without limitation, all “Protected Health Information” within the meaning of the Health Insurance Portability and Accountability Act), and (C) internal business information and
intellectual property of every kind and description of Acadia and the Subsidiaries). Executive agrees that during the Employment Period and at any time thereafter, to the fullest extent permitted by law and subject to the limitations set forth
herein (including in Section 5(d) with respect to protected whistleblower activity), Executive shall not disclose to any unauthorized person or use for Executive’s own account any of such Confidential Information,
whether or not developed by Executive, without the Board’s prior written consent, unless and to the extent that any Confidential Information (1) was known to Executive prior to the negotiation of this Agreement or the Employment Period
from a source (other than Acadia, the Subsidiaries or any of their respective agents) that, to the knowledge of Executive, was not prohibited from disclosing such information by a legal, contractual or fiduciary obligation to Acadia,
(2) becomes generally known to and available for use by the public other than as a result of Executive’s acts or omissions to act or (3) is required to be disclosed pursuant to any applicable law or court order.
(b) Use of Others’ Confidential Information. During the Employment Period, Executive shall not use or disclose any confidential
information or trade secrets, if any, of any former employers or any other Person to whom Executive has an obligation of confidentiality. If at any time during Executive’s employment with the Company, Executive believes Executive is being
asked to engage in work that will, or will be likely to, jeopardize any confidentiality or other obligations Executive may have to former employers, then Executive shall immediately advise the Board so that Executive’s duties can be modified
appropriately.
(c) Third-Party Information. Executive understands that Acadia will receive from third parties confidential or
proprietary information (“Third-Party Information”) subject to a duty on Acadia’s part to maintain the confidentiality of such information and to use it only for certain limited purposes. During the Employment Period and
thereafter, and without in any way limiting the provisions of Section 5(a), Executive will hold Third-Party Information in the strictest confidence and will not disclose to anyone (other than personnel of Acadia who need to
know such information in connection with their work for Acadia) or use, except in connection with Executive’s work for Acadia, Third-Party Information unless expressly authorized by the Board in writing.
(d) Whistleblower Protection; Permitted Disclosures. Notwithstanding anything to the contrary contained herein, no provision of this
Agreement will be interpreted so as to impede Executive (or any other individual) from (i) making any disclosure of relevant and necessary information or documents in any action, investigation, or proceeding relating to this Agreement, or as
required by law or legal process, including with respect to possible violations of law, (ii) participating, cooperating, or testifying in any action, investigation, or proceeding with, or providing information to, any governmental agency,
legislative body or any self-regulatory organization, including, but not limited to, the Department of Justice, the Securities and Exchange Commission, the Congress, and any agency Inspector General, (iii) accepting any U.S. Securities and
Exchange Commission Awards, or (iv) making other disclosures under the whistleblower provisions of federal law or regulation. In addition, nothing in this Agreement or any other agreement or Acadia policy prohibits or restricts Executive from
initiating communications with, or responding to any inquiry from, any administrative, governmental, regulatory or supervisory authority regarding any good faith concerns about possible violations of law or regulation.
6
Executive does not need the prior authorization of Acadia to make any such reports or disclosures and Executive will not be required to notify Acadia that such reports or disclosures have been
made. Pursuant to 18 U.S.C. § 1833(b), Executive will not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade secret of Acadia that (A) is made (x) in confidence to a federal,
state, or local government official, either directly or indirectly, or to Executive’s attorney and (y) solely for the purpose of reporting or investigating a suspected violation of law; or (B) is made in a complaint or other document
that is filed under seal in a lawsuit or other proceeding. If Executive files a lawsuit for retaliation by Acadia for reporting a suspected violation of law, Executive may disclose the trade secret to Executive’s attorney and use the trade
secret information in the court proceeding, if Executive files any document containing the trade secret under seal, and does not disclose the trade secret, except pursuant to court order. Nothing in this Agreement is intended to conflict with 18
U.S.C. § 1833(b) or create liability for disclosures of trade secrets that are expressly allowed by such section.
6. Ownership of
Intellectual Property, Inventions and Patents. Executive acknowledges that all discoveries, concepts, ideas, inventions, innovations, improvements, developments, methods, processes, programs, designs, analyses, drawings, reports, patent
applications, copyrightable work and mask work (whether or not including any confidential information) and all registrations or applications related thereto, all other proprietary information and all similar or related information (whether or not
patentable) which relate to Acadia’s actual or anticipated business, research and development or existing or future products or services and which are conceived, developed, contributed to, made or reduced to practice by Executive (whether
alone or jointly with others) while employed by the Company after the date of this Agreement, including any of the foregoing that constitutes any proprietary information or records (“Work Product”), belong to Acadia. Any
copyrightable work prepared in whole or in part by Executive in the course of Executive’s work for Acadia shall be deemed a “work made for hire” to the maximum extent permitted under copyright laws, and Acadia shall own all rights
therein. To the extent any such copyrightable work is not a “work made for hire,” Executive hereby assigns and agrees to assign to Acadia all right, title and interest, including, without limitation, copyright, in and to such
copyrightable work. Executive shall promptly disclose such Work Product to the Board and, at Acadia’s expense, perform all actions reasonably requested by the Board (whether during or after the Employment Period) to establish and confirm such
ownership by Acadia (including, without limitation, execution and delivery of assignments, consents, powers of attorney and other instruments). In accordance with certain state laws, Executive is hereby advised that the foregoing assignment does not
apply to any Work Product for which no equipment, supplies, facilities or trade secret information of Acadia was used and that was developed entirely on Executive’s own time, unless (a) the Work Product relates to the business or actual
or demonstrably anticipated research or development of Acadia, or (b) the Work Product results from any work performed by Executive for Acadia.
7. Non-Compete; Non-Solicit.
(a) Non-Compete. In further consideration of the compensation to be paid to Executive
hereunder, Executive acknowledges that, during the course of Executive’s employment with the Company, Executive has and shall become familiar with Acadia’s trade secrets and with other Confidential Information concerning Acadia and that
Executive’s services have been and shall be of special, unique and extraordinary value to Acadia, and, therefore, Executive agrees that,
7
during the Employment Period and for a period thereafter of twelve (12) months (the “Noncompete Period”), Executive shall not actually or attempt to, without the prior
written authorization of the Board, (i) directly or indirectly own any interest in, manage, control, participate in, consult with, render services for, or in any manner engage in any business that derives at least 25% of its gross revenue from
the business of providing behavioral healthcare and/or related services, or (ii) directly or indirectly manage, control, participate in, consult with or render services specifically with respect to any unit, division, segment or subsidiary of
any other business that engages in or otherwise competes with (or was organized for the purpose of engaging in or competing with) the business of providing behavioral healthcare and/or related services (provided that, this clause (ii) shall not
be construed to prohibit Executive from directly or indirectly owning any interest in, managing, controlling, participating in, consulting with, rendering services for, or in any manner engaging in any business activities with or for such business
generally and, for the avoidance of doubt, not specifically with respect to such unit, division, segment or subsidiary), in each case, within any geographical area in which Acadia engage in such businesses; provided that Executive shall not be
subject to the restrictions set forth in this Section 7(a) if the Employment Period is terminated by the Company without Cause or by Executive with Good Reason and for so long as the Company is in breach of its obligations
under Section 4(b) and such breach is not the subject of a good faith dispute between the Company and Executive. For purposes of this Agreement, the term “participate in” shall include, without limitation,
having any direct or indirect interest in any Person, whether as a sole proprietor, owner, stockholder, partner, joint venturer, creditor or otherwise, or rendering any direct or indirect service or assistance to any individual, corporation,
partnership, joint venture and other business entity (whether as a director, officer, manager, supervisor, employee, agent, consultant or otherwise). Nothing herein shall prohibit Executive from being a passive owner of not more than 2% of the
outstanding stock of any class of a corporation which is publicly traded, so long as Executive has no active participation in the business of such corporation.
(b) Non-Solicit. During the Employment Period and for a period thereafter of twelve
(12) months (the “Nonsolicit Period”), Executive shall not directly or indirectly through another Person (other than on behalf of Acadia), without the prior written authorization of the Board, (i) induce or attempt to
induce any employee or independent contractor of Acadia to leave the employ or services of Acadia, or in any way willfully interfere with the relationship between Acadia and any employee or independent contractor thereof, (ii) hire or seek any
business affiliation with any person who was an employee or independent contractor of Acadia at any time during the twelve (12) months prior to the Termination Date, (iii) willfully induce or attempt to induce any customer, supplier,
licensee, licensor or other business relation of Acadia to cease doing business with Acadia, or (iv) willfully interfere with the relationship between any such customer, supplier, licensor or other business relation and Acadia; provided that
Executive shall not be subject to the restrictions set forth in this Section 7(b) if the Employment Period is terminated by the Company without Cause or by Executive with Good Reason and for so long as the Company is in
breach of its obligations under Section 4(b) and such breach is not the subject of a good faith dispute between the Company and Executive.
(c) Non-Disparagement. Without limiting any other obligation of Executive pursuant to this
Agreement, Executive hereby covenants and agrees that, except as may be required by applicable law, Executive shall not make any statement, written or verbal, in any forum or media, or take any other action that is intended to or does disparage
Acadia or any of its Subsidiaries, during the Employment Period and for a period of five (5) years thereafter (the “Non-Disparagement Period”). This
Section 7(c) will not be violated by (i) truthful statements required to be made by law or legal process, or (ii) internal statements in connection with providing services to Acadia and the Subsidiaries.
8
(d) Blue-Pencil. If, at the time of enforcement of
Section 5 or 6 or this Section 7, a court shall hold that the duration, scope or area restrictions stated herein are unreasonable under circumstances then existing, the parties agree that
the maximum duration, scope or area reasonable under such circumstances shall be substituted for the stated duration, scope or area and that the court shall be allowed to revise the restrictions contained herein to cover the maximum duration, scope
and area permitted by law. Executive hereby acknowledges and represents that Executive has either consulted with independent legal counsel regarding Executive’s rights and obligations under this Agreement or knowingly and voluntarily waived
the opportunity to do so and that Executive fully understands the terms and conditions contained herein.
(e) Additional
Acknowledgments. Executive acknowledges that the provisions of Sections 5 and 6 and this Section 7 are in consideration of Executive’s employment with the Company and other good and valuable
consideration as set forth in this Agreement. In addition, Executive agrees and acknowledges that the restrictions contained in Sections 5 and 6 and this Section 7 do not preclude Executive from earning a
livelihood, nor do they unreasonably impose limitations on Executive’s ability to earn a living. In addition, Executive acknowledges (x) that the business of Acadia will be conducted throughout the United States and its territories and
beyond, (y) notwithstanding the state of organization or principal office of Acadia, or any of its executives or employees (including Executive), it is expected that Acadia will have business activities and have valuable business relationships
within its industry throughout the United States and its territories and beyond, and (z) as part of Executive’s responsibilities, Executive will be traveling throughout the United States and other jurisdictions where Acadia conducts
business during the Employment Period in furtherance of Acadia’s business relationships. Executive agrees and acknowledges that the potential harm to Acadia of the non-enforcement of any provision of
Sections 5 and 6 and this Section 7 outweighs any potential harm to Executive of its enforcement by injunction or otherwise. Executive acknowledges that Executive has carefully read this Agreement and either
consulted with legal counsel of Executive’s choosing regarding its contents or knowingly and voluntarily waived the opportunity to do so, has given careful consideration to the restraints imposed upon Executive by this Agreement and is in full
accord as to their necessity for the reasonable and proper protection of confidential and proprietary information of Acadia and the Subsidiaries now existing or to be developed in the future. Executive expressly acknowledges and agrees that each and
every restraint imposed by this Agreement is reasonable with respect to subject matter, duration and geographical area. For purposes of Sections 5 and 6 and this Section 7, references to “Acadia”
include references to Acadia and the Subsidiaries (including, without limitation, the Company).
(f) Specific Performance. In the
event of the breach or a threatened breach by Executive of any of the provisions of Section 5 or 6 or this Section 7, Acadia would suffer irreparable harm and that money damages would not be
a sufficient remedy and, in addition and supplementary to other rights and remedies existing in its favor whether under this Agreement or under any other agreement, Acadia shall be entitled to specific performance and/or injunctive or
9
other equitable relief from a court of competent jurisdiction in order to enforce or prevent any violations of the provisions hereof (without posting a bond or other security). In addition, in
the event of an alleged breach or violation by Executive of this Section 7, the Noncompete Period or the Nonsolicit Period, as applicable, shall be tolled until such breach or violation has been duly cured.
8. Executive’s Representations. Executive hereby represents and warrants to the Company that (a) the execution, delivery and
performance of this Agreement by Executive do not and shall not conflict with, breach, violate or cause a default under any contract, agreement, instrument, order, judgment or decree to which Executive is a party or by which Executive is bound,
(b) except as previously disclosed to the Company in writing (a copy of each such agreement having been provided to the Company prior to the Signing Date or being publicly available on EDGAR as of the Signing Date), Executive is not a party to
or bound by any employment agreement, noncompete agreement or confidentiality agreement with any other person or entity other than Acadia, (c) except as previously disclosed to the Company in writing, Executive took nothing with Executive which
belonged to any former employer when Executive left Executive’s prior position and Executive has nothing that contains any information which belongs to any former employer, in either case which would reasonably be likely to result in any
liability to Acadia or any Subsidiary, and (d) upon the execution and delivery of this Agreement by the Company, this Agreement shall be the valid and binding obligation of Executive, enforceable in accordance with its terms. Executive hereby
acknowledges and represents that Executive has either consulted with independent legal counsel regarding Executive’s rights and obligations under this Agreement or knowingly and voluntarily waived the opportunity to do so and that Executive
fully understands the terms and conditions contained herein.
9. Definitions. For purposes of this Agreement, the following terms
shall have the meanings set forth below:
“Cause” shall mean with respect to Executive one or more of the following:
(i) the conviction of or plea of nolo contendere to a felony or other crime involving moral turpitude or the conviction of any crime involving misappropriation, embezzlement or fraud with respect to Acadia or any of the Subsidiaries or any of
their customers, suppliers or other business relations, (ii) conduct outside the scope of Executive’s duties and responsibilities under this Agreement that causes Acadia or any of the Subsidiaries substantial public disgrace or disrepute
or economic harm, (iii) repeated failure to perform duties consistent with this Agreement as reasonably directed by the Board, (iv) any act or knowing omission aiding or abetting a competitor, supplier or customer of Acadia or any of the
Subsidiaries to the disadvantage or detriment of Acadia and the Subsidiaries, (v) breach of fiduciary duty, gross negligence or willful misconduct with respect to Acadia or any of the Subsidiaries, (vi) an administrative or other
proceeding results in the suspension or debarment of Executive from participation in any contracts with, or programs of, the United States or any of the fifty states or any agency or department thereof, or (vii) any other material breach by
Executive of this Agreement or any other agreement between Executive and Acadia or any of the Subsidiaries, which is not cured to the Board’s reasonable satisfaction within thirty (30) days after written notice thereof to Executive.
10
“Disabled” means any physical or mental disability or infirmity that has
prevented the performance of Executive’s duties, with or without a reasonable accommodation, for a period of (a) one hundred twenty (120) consecutive days or (b) one hundred eighty
(180) non-consecutive days during any twelve (12)-month period. Any question as to the existence, extent or potentiality of Executive’s Disability upon which Executive and the Company cannot agree
shall be determined by a qualified, independent physician selected by the Company and reasonably approved by Executive (or Executive’s representative).
“Good Reason” shall mean if Executive resigns Executive’s employment with the Company as a result of one or more of
the following actions (in each case taken without Executive’s written consent): (i) a reduction in Executive’s Base Salary; (ii) a material diminution of Executive’s job duties or responsibilities inconsistent with
Executive’s position; (iii) any other material breach by the Company or Acadia (or their successors) of this Agreement; or (iv) a required relocation of Executive’s principal place of employment; provided that, none of
the events described in clauses (i) through (iv) above shall constitute Good Reason unless Executive shall have notified the Company and/or Acadia in writing describing the event which constitutes Good Reason within ninety (90) days
after the occurrence of such event and then only if the Company and/or Acadia and the Subsidiaries shall have failed to cure such event within thirty (30) days after the Company’s and/or Acadia’s receipt of such written notice and
Executive elects to terminate Executive’s employment as a result at the end of such thirty (30) day period.
“Person” shall mean an individual, a partnership, a corporation (whether or not for profit), a limited liability company,
an association, a joint stock company, a trust, a joint venture, or other business entity, an unincorporated organization and a governmental entity or any department, agency or political subdivision thereof.
“Subsidiary” shall mean any corporation or other entity of which the securities or other ownership interests having the
voting power to elect a majority of the board of directors or other governing body are, at the time of determination, owned by Acadia or of which Acadia serves as the managing member or in a similar capacity or of which Acadia holds a majority of
the partnership or limited liability company or similar interests or is otherwise entitled to receive a majority of distributions made by it, in each case directly or through one or more Subsidiaries.
10. Survival. Sections 4 through 27 (other than Section 22) shall survive and continue in full
force in accordance with their terms notwithstanding the expiration or termination of the Employment Period.
11. Notices. Any
notice provided for in this Agreement shall be in writing and shall be personally delivered, sent by facsimile (with hard copy to follow), sent by reputable overnight courier service, or mailed by first class mail, return receipt requested, to the
recipient at the address below indicated:
Notices to Executive:
At the address on the books and records of the Company at the time of such notice.
Notices to the Company:
Acadia
Healthcare Company, Inc.
11
4020 Aspen Grove Drive, Suite 900
Franklin, TN 37067
Attention:
General Counsel
or such other address or to the attention of such other Person as the recipient party shall have specified by prior written notice to the
sending party. Any notice under this Agreement shall be deemed to have been given when so delivered or sent by facsimile (subject to automatic proof of transmission), one day after being sent by overnight courier or three days after being mailed by
first class mail, return receipt requested, as applicable.
12. Severability. Whenever possible, each provision of this Agreement
shall be interpreted in such manner as to be effective and valid under applicable law, but if any provision of this Agreement is held to be invalid, illegal or unenforceable in any respect under any applicable law or rule in any jurisdiction, such
invalidity, illegality or unenforceability shall not affect any other provision of this Agreement or any action in any other jurisdiction, but this Agreement shall be reformed, construed and enforced in such jurisdiction as if such invalid, illegal
or unenforceable provision had never been contained herein.
13. Complete Agreement. This Agreement and those documents expressly
referred to herein embody the complete agreement and understanding among the parties with respect to, and supersede and preempt any prior understandings, agreements or representations by or among the parties, written or oral, which may have related
to, the subject matter hereof in any way.
14. No Strict Construction. The language used in this Agreement shall be deemed to be
the language chosen by the parties hereto to express their mutual intent, and no rule of strict construction shall be applied against any party.
15. Counterparts. This Agreement may be executed in separate counterparts (including by means of facsimile or by electronic
transmission in portable document format (pdf) or comparable electronic transmission), each of which is deemed to be an original and all of which taken together constitute one and the same agreement.
16. Successors and Assigns. This Agreement is personal in nature and neither of the parties hereto shall, without the consent of the
other, assign, transfer or delegate this Agreement or any rights or obligations hereunder; provided that (i) this Agreement will inure to the benefit of and be enforceable by Executive’s personal or legal representatives,
executors, administrators, successors, heirs, distributees and legatees (but otherwise will not otherwise be assignable, transferable or delegable by Executive), and (ii) this Agreement will be assignable, transferable or delegable by the
Company, without the consent of Executive, to Acadia or any of the Subsidiaries or to any successor (whether direct or indirect, in whatever form of transaction) to all or substantially all of the business or assets of the Company or Acadia or the
Subsidiaries (none of which shall constitute a termination of Executive’s employment hereunder).
12
17. Choice of Law and Forum. All issues and questions concerning the construction,
validity, enforcement and interpretation of this Agreement and the exhibits and schedules hereto, other than Sections 5, 6 and 7 of this Agreement, shall be governed by, and construed in accordance with, the laws of the State of
Delaware, without giving effect to any choice of law or conflict of law rules or provisions (whether of the State of Delaware or any other jurisdiction) that would cause the application of the laws of any jurisdiction other than the State of
Delaware. All issues and questions concerning the construction, validity, enforcement and interpretation of Sections 5, 6 and 7 of this Agreement shall be governed by, and construed in accordance with, the laws of the State of
Tennessee, without giving effect to any choice of law or conflict of law rules or provisions (whether of the State of Tennessee or any other jurisdiction) that would cause the application of the laws of any jurisdiction other than the State of
Tennessee. The parties agree that any dispute arising out of or relating to this Agreement, exclusively shall be brought in the state courts located in Williamson County, Tennessee or the United States District Court for the Middle District of
Tennessee. Each party hereby waives any objection to the personal or subject matter jurisdiction and venue of such courts.
18.
Amendment and Waiver. The provisions of this Agreement may be amended or waived only with the prior written consent of the Company (as approved by the Board) and Executive, and no course of conduct or course of dealing or failure or delay by
any party hereto in enforcing or exercising any of the provisions of this Agreement (including, without limitation, the Company’s right to terminate the Employment Period for Cause) shall affect the validity, binding effect or enforceability
of this Agreement or be deemed to be an implied waiver of any provision of this Agreement.
19. Insurance. The Company may, at its
discretion, apply for and procure in its own name and for its own benefit life and/or disability insurance on Executive in any amount or amounts considered advisable. Executive agrees to cooperate in any medical or other examination, supply any
information and execute and deliver any applications or other instruments in writing as may be reasonably necessary to obtain and constitute such insurance.
20. Indemnification and Reimbursement of Payments on Behalf of Executive. Acadia and the Subsidiaries shall be entitled to deduct or
withhold from any amounts owing from Acadia or any of the Subsidiaries to Executive any federal, state, local or foreign withholding taxes, excise tax, or employment taxes (“Taxes”) imposed with respect to Executive’s
compensation or other payments from Acadia or any of the Subsidiaries or Executive’s ownership interest in Acadia or any of the Subsidiaries (including, without limitation, wages, bonuses, dividends, the receipt or exercise of equity options
and/or the receipt or vesting of restricted equity), as may be required to be deducted or withheld by any applicable law or regulation. In the event Acadia or any of the Subsidiaries does not make such deductions or withholdings, Executive shall
indemnify Acadia and the Subsidiaries for any amounts paid with respect to any such Taxes, together (if such failure to withhold was at the written direction of Executive or if Executive was informed in writing by Acadia or such Subsidiary that such
deductions or withholdings were not made) with any interest, penalties and related expenses thereto.
21. Waiver of Jury Trial. AS
A SPECIFICALLY BARGAINED FOR INDUCEMENT FOR EACH OF THE PARTIES HERETO TO ENTER INTO THIS AGREEMENT (AFTER HAVING THE OPPORTUNITY TO CONSULT WITH COUNSEL), EACH PARTY HERETO EXPRESSLY WAIVES THE RIGHT TO TRIAL BY JURY IN ANY LAWSUIT OR PROCEEDING
RELATING TO OR ARISING IN ANY WAY FROM THIS AGREEMENT OR THE MATTERS CONTEMPLATED HEREBY.
13
22. Opportunity. During the Employment Period, Executive shall submit to the Board
all investment or business opportunities of which Executive becomes aware and which are within the scope and investment objectives of Acadia or any of the Subsidiaries.
23. Executive’s Cooperation. During the Employment Period Executive shall cooperate with Acadia and the Subsidiaries in any
internal investigation or administrative, regulatory or judicial investigation or proceeding or any dispute with any third party as reasonably requested by Acadia or the Subsidiaries (including, without limitation, Executive being available to
Acadia and the Subsidiaries upon reasonable notice for interviews and factual investigations, appearing at Acadia’s or any of the Subsidiaries’ request to give testimony without requiring service of a subpoena or other legal process,
volunteering Acadia and the Subsidiaries all pertinent information and turning over to Acadia and the Subsidiaries all relevant documents which are or may come into Executive’s possession, all at times and on schedules that are reasonably
consistent with Executive’s other permitted activities and commitments), all at Acadia’s or the Subsidiaries’ sole cost and expense.
24. Delivery by Facsimile or PDF. This Agreement, the agreements referred to herein, and each other agreement or instrument entered
into in connection herewith or therewith or contemplated hereby or thereby, and any amendments hereto or thereto, to the extent signed and delivered by means of a facsimile machine or electronic transmission in pdf, shall be treated in all manner
and respects as an original agreement or instrument and shall be considered to have the same binding legal effect as if it were the original signed version thereof delivered in person. At the request of any party hereto or to any such agreement or
instrument, each other party hereto or thereto shall re-execute original forms thereof and deliver them to all other parties. No party hereto or to any such agreement or instrument shall raise the use of a
facsimile machine or electronic transmission in pdf to deliver a signature or the fact that any signature or agreement or instrument was transmitted or communicated through the use of a facsimile machine or electronic transmission in pdf as a
defense to the formation or enforceability of a contract and each such party forever waives any such defense.
25. Indemnification and
Directors and Officers Insurance.
(a) During the Employment Period and for a period of six (6) years thereafter, the Company
shall, to the fullest extent permitted under applicable law, indemnify and hold harmless Executive against all costs and expenses (including attorneys’ fees), judgments, fines, losses, claims, damages, liabilities and settlement amounts paid
in connection with any claim, action, suit, proceeding or investigation (whether arising before or after the Start Date), whether civil, criminal, administrative or investigative, arising out of or pertaining to any action or omission in their
capacity as an officer, director, employee, fiduciary or agent of the Company (or Acadia or any Subsidiary). In the event of any such claim, action, suit, proceeding or investigation, (i) the Company shall pay the reasonable fees and expenses
of counsel selected by Executive promptly after statements therefor are received, (ii) neither the Company, Acadia nor any Subsidiary shall settle, compromise or consent to the entry of any judgment in any pending or threatened action to which
Executive is a party (and in respect of which indemnification could be sought by Executive hereunder), unless such settlement, compromise or consent includes an unconditional release of Executive from all liability arising out of such action, or
Executive otherwise consents (which consent shall not be unreasonably withheld, conditioned or delayed), and (iii) the Company,
14
Acadia and the applicable Subsidiaries shall cooperate in the defense of any such matter. In the event that any claim for indemnification is asserted or made within the Employment Period or the
six (6) year period thereafter, all rights of Executive to indemnification in respect of such claim shall continue until the final disposition of such claim. The rights of Executive under this Section 25(a) shall be in
addition to any rights Executive may have under the organizational documents of the Company, Acadia or any Subsidiary, under any law, or under any agreement of Executive with the Company, Acadia or any Subsidiary.
(b) During the Employment Period and for a period of six (6) years thereafter, the Company, or any successor to the Company, shall
purchase and maintain, at its own expense, directors and officers liability insurance providing coverage for Executive in the same or greater amount as for members of the Board.
26. Legal Fees and Expenses. In the event any litigation or other court action, arbitration or similar adjudicatory proceeding (a
“Proceeding”) is commenced or threatened by any party hereto (the “Claiming Party”) to enforce its rights under this Agreement against any other party hereto (the “Defending Party”), if the
Defending Party is the prevailing party in such Proceeding, all fees, costs and expenses, including, without limitation, reasonable attorneys fees and court costs, incurred by the Defending Party in such Proceeding, will be reimbursed by the
Claiming Party, and, if the Claiming Party is the prevailing party in such Proceeding, all fees, costs and expenses, including, without limitation, reasonable attorneys fees and court costs, incurred by the Claiming Party in such Proceeding, will be
reimbursed by the Defending Party; provided that if the Defending Party prevails in part, and loses in part, in such Proceeding, the court, arbitrator or other adjudicator presiding over such Proceeding shall award a reimbursement of the fees, costs
and expenses incurred by the Claiming Party and the Defending Party on an equitable basis. For purposes of this Section 26, and without limiting the generality of the foregoing, the Defending Party will be deemed to have
prevailed in any Proceeding if the Claiming Party commences or threatens such Proceeding and (i) the underlying claim(s) in such Proceeding are subsequently dropped or dismissed, or (ii) the Defending Party defeats any such claim(s).
27. Acadia Guarantee. Acadia unconditionally guarantees and promises to pay and perform, upon Executive’s demand following a
default by the Company, any and all obligations of the Company from time to time owed to Executive under this Agreement, subject to any applicable cure period. Acadia further agrees that if the Company shall fail to fulfill any of its obligations
under this Agreement, Acadia will perform the same on demand as a principal obligor, and not as a surety. This is a continuing guarantee of the obligations and may not be revoked and shall not otherwise terminate unless and until the obligations of
the Company have been paid and performed in full. Acadia represents and warrants that it will receive a substantial benefit from Company’s employment of Executive, which employment gives rise to the obligations of the Company under this
Agreement. Acadia acknowledges that Executive would not execute this Agreement if it did not receive this guarantee.
*
* * * *
15
IN WITNESS WHEREOF, the parties hereto have executed this Employment Agreement as of the
date first written above.
THE COMPANY:
ACADIA MANAGEMENT COMPANY, LLC
By:
/s/ Debra Osteen
Name: Debra Osteen
Its: Chief Executive Officer
EXECUTIVE:
/s/ David M. Duckworth
Name: David M. Duckworth
ACKNOWLEDGED AND AGREED:
ACADIA HEALTHCARE COMPANY, INC.,
solely with respect to Sections 7 and 27
By:
/s/ Debra Osteen
Name: Debra Osteen
Its: Chief Executive Officer
[Signature Page to Employment Agreement]
EXHIBIT A
Board Service
•
Integrative Life Network
•
Team Mobile Health Care
•
Other volunteer boards include Tennessee Soccer Club and West Nashville Young Life
EXHIBIT B
GENERAL RELEASE1
I, David M. Duckworth, in consideration of and subject to the performance by Acadia Management Company, Inc., a Delaware corporation (together
with its affiliates, the “Company”), of the Company’s obligations under the Employment Agreement dated as of April 22, 2026 (the “Agreement”), do hereby release and forever discharge as of the date
hereof the Company and all present, former and future managers, directors, officers, employees, successors and assigns of the Company and direct or indirect owners (collectively, the “Released Parties”) to the extent provided
below (this “General Release”). The Released Parties are intended to be third-party beneficiaries of this General Release, and this General Release may be enforced by each of them in accordance with the terms hereof in respect of
the rights granted to such Released Parties hereunder. Terms used herein but not otherwise defined shall have the meanings given to them in the Agreement.
1.
I understand that any payments or benefits paid or granted to me under Section 4 of the Agreement
represent, in part, consideration for signing this General Release and are not salary, wages or benefits to which I was already entitled. I understand and agree that I will not receive certain of the payments and benefits specified in
Section 4, unless I execute this General Release and do not revoke this General Release within the time period permitted hereafter. Such payments and benefits will not be considered compensation for purposes of any employee benefit plan,
program, policy or arrangement maintained or hereafter established by the Company.
2.
Except as provided in paragraphs 5 and 6 below and except for the provisions of the Agreement which expressly
survive the termination of my employment with the Company, I knowingly and voluntarily (for myself, my heirs, executors, administrators and assigns) release and forever discharge the Company and the other Released Parties from any and all claims,
suits, controversies, actions, causes of action, cross-claims, counter-claims, demands, debts, compensatory damages, liquidated damages, punitive or exemplary damages, other damages, claims for costs and attorneys’ fees, or liabilities of any
nature whatsoever in law and in equity, both past and present (through the date that this General Release becomes effective and enforceable) and whether known or unknown, suspected, or claimed against the Company or any of the Released Parties which
I, my spouse, or any of my heirs, executors, administrators or assigns, may have, including those that arise out of or are connected with my employment with, or my separation or termination from, the Company (including, but not limited to, any
allegation, claim or violation, arising under: Title VII of the Civil Rights Act of 1964, as amended; the Civil Rights Act of 1991; the Age Discrimination in Employment Act of 1967, as amended (including the Older Workers Benefit Protection Act);
the Equal Pay Act of 1963, as amended; the Americans with Disabilities Act of 1990; the Family and Medical Leave Act of 1993; the Worker Adjustment Retraining and Notification Act; the Employee Retirement Income Security Act of 1974; any applicable
Executive Order Programs; the Fair Labor Standards Act; or their state or local counterparts; or under any other federal, state or local civil or human
1
Note to Draft: Subject to updates to the extent necessary for applicable governing law.
rights law, or under any other local, state, or federal law, regulation or ordinance; or under any public policy, contract or tort, or under common law; or arising under any policies,
practices or procedures of the Company; or any claim for wrongful discharge, breach of contract, infliction of emotional distress, defamation; or any claim for costs, fees, or other expenses, including attorneys’ fees incurred in these
matters) (all of the foregoing collectively referred to herein as the “Claims”).
3.
The released claims described in paragraph 2 hereof include all such claims, whether known or unknown by me.
4.
I represent that I have made no assignment or transfer of any right, claim, demand, cause of action, or other
matter covered by paragraph 2 above.
5.
I agree that this General Release does not waive or release any rights or claims that I may have under the Age
Discrimination in Employment Act of 1967 which arise after the date I execute this General Release. I acknowledge and agree that my separation from employment with the Company in compliance with the terms of the Agreement shall not serve as the
basis for any claim or action (including, without limitation, any claim under the Age Discrimination in Employment Act of 1967).
6.
I agree that I hereby waive all rights to sue or obtain equitable, remedial or punitive relief from any or all
Released Parties of any kind whatsoever in respect of any Claim, including, without limitation, reinstatement, back pay, front pay, and any form of injunctive relief. Notwithstanding the above, I further acknowledge that I am not waiving and am not
being required to waive any right that cannot be waived under law, including the right to file an administrative charge or participate in an administrative investigation or proceeding; provided, however, that I disclaim and waive any right to share
or participate in any monetary award resulting from the prosecution of such charge or investigation or proceeding, other than any such award to which I become entitled pursuant to Section 922 of the Dodd-Frank Wall Street Reform and Consumer
Protection Act or awards under other whistleblower laws that cannot be waived by law. Additionally, I am not waiving (and nothing set forth herein shall be deemed a release of) (a) any right to any earned and accrued salary, bonus, vacation,
benefits, expense reimbursements, or any severance benefits to which I am entitled under the Agreement, (b) any claim relating to directors’ and officers’ liability insurance coverage or any right of indemnification under the
Company’s organizational documents, applicable law or otherwise, including, without limitation, Sections 25 and 26 of the Agreement, (c) claims for workers’ compensation benefits under any of the Company’s workers’
compensation insurance policies or funds, (d) claims related to my rights under the Consolidated Budget Reconciliation Act of 1985, as amended and/or (e) any obligations of the Company under this General Release, including my rights to
enforce this General Release.
7.
In signing this General Release, I acknowledge and intend that it shall be effective as a bar to each and every
one of the Claims hereinabove mentioned or implied. I expressly consent that this General Release shall be given full force and effect according to each and all of its express terms and provisions, including those relating to unknown and unsuspected
Claims (notwithstanding any state or local statute that expressly limits the effectiveness of
19
a general release of unknown, unsuspected and unanticipated Claims), if any, as well as those relating to any other Claims hereinabove mentioned or implied. I acknowledge and agree that this
waiver is an essential and material term of this General Release and that without such waiver the Company would not have agreed to the terms of the Agreement. I further agree that in the event I should bring a Claim seeking damages against the
Company, or in the event I should seek to recover against the Company in any Claim brought by a governmental agency on my behalf, this General Release shall serve as a complete defense to such Claims to the maximum extent permitted by law. I
further agree that I am not aware of any pending claim of the type described in paragraph 2 above as of the execution of this General Release.
8.
I agree that neither this General Release, nor the furnishing of the consideration for this General Release,
shall be deemed or construed at any time to be an admission by the Company, any Released Party or myself of any improper or unlawful conduct.
9.
I agree that if I violate this General Release by suing the Company or the other Released Parties, I will pay
all costs and expenses of defending against the suit incurred by the Released Parties, including reasonable attorneys’ fees.
10.
Any non-disclosure provision in this General Release does not prohibit
or restrict me (or my attorney) from responding to any inquiry about this General Release or its underlying facts and circumstances by the Securities and Exchange Commission (SEC), the Financial Industry Regulatory Authority (FINRA), any other
self-regulatory organization or any governmental entity.
11.
I hereby acknowledge that Sections 4 through 27 (other than Section 22) of the Agreement shall survive my
execution of this General Release.
12.
I represent that I am not aware of any claim by me other than the claims that are released by this General
Release. I acknowledge that I may hereafter discover claims or facts in addition to or different than those which I now know or believe to exist with respect to the subject matter of the release set forth in paragraph 2 above and which, if known or
suspected at the time of entering into this General Release, may have materially affected this General Release and my decision to enter into it.
13.
Notwithstanding anything in this General Release to the contrary, this General Release shall not relinquish,
diminish, or in any way affect any rights or claims arising out of any breach by the Company or by any Released Party of the Agreement after the date hereof.
14.
Whenever possible, each provision of this General Release shall be interpreted in, such manner as to be
effective and valid under applicable law, but if any provision of this General Release is held to be invalid, illegal or unenforceable in any respect under any applicable law or rule in any jurisdiction, such invalidity, illegality or
unenforceability shall not affect any other provision or any other jurisdiction, but this General Release shall be reformed, construed and enforced in such jurisdiction as if such invalid, illegal or unenforceable provision had never been contained
herein.
20
BY SIGNING THIS GENERAL RELEASE, I REPRESENT AND AGREE THAT:
(a)
I HAVE READ IT CAREFULLY;
(b)
I UNDERSTAND ALL OF ITS TERMS AND KNOW THAT I AM GIVING UP IMPORTANT RIGHTS, INCLUDING BUT NOT LIMITED TO,
RIGHTS UNDER THE AGE DISCRIMINATION IN EMPLOYMENT ACT OF 1967, AS AMENDED; TITLE VII OF THE CIVIL RIGHTS ACT OF 1964, AS AMENDED; THE EQUAL PAY ACT OF 1963; THE AMERICANS WITH DISABILITIES ACT OF 1990; AND THE EMPLOYEE RETIREMENT INCOME SECURITY ACT
OF 1974, AS AMENDED;
(c)
I VOLUNTARILY CONSENT TO EVERYTHING IN IT;
(d)
I HAVE BEEN ADVISED TO CONSULT WITH AN ATTORNEY BEFORE EXECUTING IT AND I HAVE DONE SO OR, AFTER CAREFUL
READING AND CONSIDERATION, I HAVE CHOSEN NOT TO DO SO OF MY OWN VOLITION;
(e)
I HAVE HAD AT LEAST [21][45] DAYS FROM THE DATE OF MY RECEIPT OF THIS RELEASE TO CONSIDER IT, AND
THE CHANGES MADE SINCE MY RECEIPT OF THIS RELEASE ARE NOT MATERIAL OR WERE MADE AT MY REQUEST AND WILL NOT RESTART THE REQUIRED [21][45]-DAY PERIOD;
(f)
I UNDERSTAND THAT I HAVE SEVEN (7) DAYS AFTER THE EXECUTION OF THIS RELEASE TO REVOKE IT AND THAT THIS
RELEASE SHALL NOT BECOME EFFECTIVE OR ENFORCEABLE UNTIL THE REVOCATION PERIOD HAS EXPIRED;
(g)
I HAVE SIGNED THIS GENERAL RELEASE KNOWINGLY AND VOLUNTARILY AND WITH THE ADVICE OF ANY COUNSEL RETAINED TO
ADVISE ME WITH RESPECT TO IT; AND
(h)
I AGREE THAT THE PROVISIONS OF THIS GENERAL RELEASE MAY NOT BE AMENDED, WAIVED, CHANGED OR MODIFIED EXCEPT BY
AN INSTRUMENT IN WRITING SIGNED BY AN AUTHORIZED REPRESENTATIVE OF THE COMPANY AND BY ME.
SIGNED: ____________________________
DATE: ______________________
21
EX-99.1
EX-99.1
Filename: d116826dex991.htm · Sequence: 3
EX-99.1
Exhibit 99.1
Acadia Healthcare Appoints David Duckworth as Interim Chief Financial Officer
Reaffirms Financial Guidance for First Quarter and Full Year 2026
FRANKLIN, Tenn. – April 23, 2026 – Acadia Healthcare Company, Inc. (“Acadia” or the
“Company”) (NASDAQ: ACHC) today announced the appointment of David Duckworth, former Chief Financial Officer of Acadia, as Interim Chief Financial Officer, effective May 1, 2026. Duckworth succeeds Todd Young, who is departing from
the Company to pursue a CFO role at a private equity-backed animal health company. Young will remain with the Company through April 30, 2026, and will participate in the Company’s first quarter earnings call scheduled for the morning of
April 30.
Debra K. Osteen, Chief Executive Officer of Acadia, said, “We are pleased to welcome David back as Interim Chief Financial Officer. He
brings a deep understanding of Acadia, our operations, and our industry, along with strong relationships with the Company’s leadership team and Board. David’s experience will be invaluable as we continue executing our strategic
priorities to position Acadia for near and long-term success and value creation.”
The Company expects Duckworth to serve as Interim Chief Financial
Officer at least until the completion of the previously announced search for a permanent Chief Executive Officer, which remains ongoing.
Osteen
continued, “On behalf of the Board and our entire team, I want to thank Todd for his leadership and contributions during his time with Acadia. We appreciate his dedication and wish him all the best in his next chapter.”
Reaffirms First Quarter and Full-Year 2026 Outlook
The
Company is reaffirming its first quarter and full-year 2026 financial guidance as updated by its February 25, 2026 press release and reiterated in conjunction with management’s presentation at the Barclays 28th Annual Global
Healthcare Conference on March 10, 2026. The Company continues to expect:
First Quarter 2026
•
Revenue of $820 to $830 million
•
Adjusted EBITDA of $130 to $137 million
•
Adjusted earnings per diluted share of $0.25 to $0.30
Full-Year 2026
•
Revenue of $3.37 to $3.45 billion
•
Adjusted EBITDA of $575 to $610 million
•
Adjusted earnings per diluted share of $1.30 to $1.55
•
Capital expenditures of $255 to $280 million
The Company will issue first quarter 2026 results after the close of the market on April 29, and host its earnings call on April 30 at 9 a.m.
Eastern Daylight Time. Additional details can be found on Acadia’s website, https://www.acadiahealthcare.com/.
About David Duckworth
Mr. Duckworth previously served as Acadia Healthcare’s Chief Financial Officer from 2012 to 2023. He joined Acadia in April 2011 as Chief
Accounting Officer, after having served since May 2010 as Director of Finance at Emdeon Inc., a leading provider of revenue and payment cycle management and clinical information exchange solutions, which was then a NYSE-listed company. Previously,
Mr. Duckworth was a Manager with Ernst & Young LLP, which he joined in 2002. He earned a bachelor’s degree in accounting and a Master of Accountancy, both from the University of Tennessee, Knoxville.
Forward-Looking Information
This press release contains
“forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), including statements
related to our strategy, growth, and anticipated operating results for future periods. Generally, words such as “may,” “will,” “should,” “could,” “anticipate,” “expect,”
“intend,” “estimate,” “plan,” “continue,” and “believe” or the negative of or other variation on these and other similar expressions identify forward-looking statements. These
forward-looking statements are made only as of the date of this press release. We do not undertake to update or revise the forward-looking statements, whether as a result of new information, future events or otherwise. Forward-looking statements are
based on current expectations and involve risks and uncertainties and our future results could differ significantly from those expressed or implied by our forward-looking statements. Factors that may cause actual results to differ materially
include, without limitation, (i) potential difficulties in successfully integrating the operations of acquired facilities or realizing the expected benefits and synergies of our facility expansions, acquisitions, joint ventures and de novo
transactions; (ii) Acadia’s ability to add beds, expand services, enhance marketing programs and improve efficiencies at its facilities; (iii) potential reductions in payments received by Acadia from government and commercial payors,
including because of the significant changes to Medicaid financing mechanisms introduced by the One Big Beautiful Bill Act (“OBBBA”) enacted on July 4, 2025; (iv) the occurrence of patient incidents, governmental investigations,
litigation and adverse regulatory actions, which could adversely affect the price of our common stock and result in substantial payments and incremental regulatory burdens; (v) the risk that Acadia may not generate sufficient cash from
operations to service its debt and meet its working capital and capital expenditure
requirements; (vi) changes in expectations resulting from actuarial and other reviews of the Company’s liability reserves and other aspects of its business; (vii) potential
disruptions to our information technology systems or a cybersecurity incident; and (viii) potential operating difficulties, including, without limitation, disruption to the U.S. economy and financial markets; reduced admissions and
patient volumes, including, without limitation, due to OBBBA’s introduction of work or community engagement requirements in the Medicaid expansion population; increased costs relating to labor, supply chain and other expenditures; changes in
competition and client preferences; and general economic or industry conditions that may prevent Acadia from realizing the expected benefits of its business strategies. These factors and others are more fully described in Acadia’s periodic
reports and other filings with the Securities and Exchange Commission.
About Acadia
Acadia is a leading provider of behavioral healthcare services across the United States. As of December 31, 2025, Acadia operated a network of 277
behavioral healthcare facilities with over 12,500 beds in 40 states and Puerto Rico. With approximately 25,000 employees serving more than 84,000 patients daily, Acadia is the largest stand-alone behavioral healthcare company in
the U.S. Acadia provides behavioral healthcare services to its patients in a variety of settings, including inpatient psychiatric hospitals, specialty treatment facilities, residential treatment centers and outpatient clinics.
Media Contact:
eric.barnes@acadiahealthcare.com
Investor Contact:
InvestorRelations@acadiahealthcare.com
GRAPHIC
GRAPHIC
Filename: g116826g0423113206080.jpg · Sequence: 7
Binary file (7016 bytes)
Download g116826g0423113206080.jpg
XML — IDEA: XBRL DOCUMENT
XML
Filename: R1.htm · Sequence: 9
v3.26.1
Document and Entity Information
Apr. 22, 2026
Cover [Abstract]
Amendment Flag
false
Entity Central Index Key
0001520697
Document Type
8-K
Document Period End Date
Apr. 22, 2026
Entity Registrant Name
Acadia Healthcare Company, Inc.
Entity Incorporation State Country Code
DE
Entity File Number
001-35331
Entity Tax Identification Number
45-2492228
Entity Address, Address Line One
4020 Aspen Grove Drive
Entity Address, Address Line Two
Suite 900
Entity Address, City or Town
Franklin
Entity Address, State or Province
TN
Entity Address, Postal Zip Code
37067
City Area Code
(615)
Local Phone Number
861-6000
Written Communications
false
Soliciting Material
false
Pre Commencement Tender Offer
false
Pre Commencement Issuer Tender Offer
false
Security 12b Title
Common Stock, $0.01 par value
Trading Symbol
ACHC
Security Exchange Name
NASDAQ
Entity Emerging Growth Company
false
X
- Definition
Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.
+ References
No definition available.
+ Details
Name:
dei_AmendmentFlag
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Area code of city
+ References
No definition available.
+ Details
Name:
dei_CityAreaCode
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Cover page.
+ References
No definition available.
+ Details
Name:
dei_CoverAbstract
Namespace Prefix:
dei_
Data Type:
xbrli:stringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.
+ References
No definition available.
+ Details
Name:
dei_DocumentPeriodEndDate
Namespace Prefix:
dei_
Data Type:
xbrli:dateItemType
Balance Type:
na
Period Type:
duration
X
- Definition
The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.
+ References
No definition available.
+ Details
Name:
dei_DocumentType
Namespace Prefix:
dei_
Data Type:
dei:submissionTypeItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Address Line 1 such as Attn, Building Name, Street Name
+ References
No definition available.
+ Details
Name:
dei_EntityAddressAddressLine1
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Address Line 2 such as Street or Suite number
+ References
No definition available.
+ Details
Name:
dei_EntityAddressAddressLine2
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Name of the City or Town
+ References
No definition available.
+ Details
Name:
dei_EntityAddressCityOrTown
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Code for the postal or zip code
+ References
No definition available.
+ Details
Name:
dei_EntityAddressPostalZipCode
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Name of the state or province.
+ References
No definition available.
+ Details
Name:
dei_EntityAddressStateOrProvince
Namespace Prefix:
dei_
Data Type:
dei:stateOrProvinceItemType
Balance Type:
na
Period Type:
duration
X
- Definition
A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details
Name:
dei_EntityCentralIndexKey
Namespace Prefix:
dei_
Data Type:
dei:centralIndexKeyItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Indicate if registrant meets the emerging growth company criteria.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details
Name:
dei_EntityEmergingGrowthCompany
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.
+ References
No definition available.
+ Details
Name:
dei_EntityFileNumber
Namespace Prefix:
dei_
Data Type:
dei:fileNumberItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Two-character EDGAR code representing the state or country of incorporation.
+ References
No definition available.
+ Details
Name:
dei_EntityIncorporationStateCountryCode
Namespace Prefix:
dei_
Data Type:
dei:edgarStateCountryItemType
Balance Type:
na
Period Type:
duration
X
- Definition
The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details
Name:
dei_EntityRegistrantName
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details
Name:
dei_EntityTaxIdentificationNumber
Namespace Prefix:
dei_
Data Type:
dei:employerIdItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Local phone number for entity.
+ References
No definition available.
+ Details
Name:
dei_LocalPhoneNumber
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 13e
-Subsection 4c
+ Details
Name:
dei_PreCommencementIssuerTenderOffer
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 14d
-Subsection 2b
+ Details
Name:
dei_PreCommencementTenderOffer
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Title of a 12(b) registered security.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b
+ Details
Name:
dei_Security12bTitle
Namespace Prefix:
dei_
Data Type:
dei:securityTitleItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Name of the Exchange on which a security is registered.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection d1-1
+ Details
Name:
dei_SecurityExchangeName
Namespace Prefix:
dei_
Data Type:
dei:edgarExchangeCodeItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 14a
-Subsection 12
+ Details
Name:
dei_SolicitingMaterial
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Trading symbol of an instrument as listed on an exchange.
+ References
No definition available.
+ Details
Name:
dei_TradingSymbol
Namespace Prefix:
dei_
Data Type:
dei:tradingSymbolItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Securities Act
-Number 230
-Section 425
+ Details
Name:
dei_WrittenCommunications
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration